CBS001 / Centessa, Eli Lilly - LARVOL DELTA

Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=56 | Terminated | Sponsor: Capella Bioscience Ltd | N=88 ➔ 56 | Trial completion date: Dec 2023 ➔ Aug 2023 | Suspended ➔ Terminated | Trial primary completion date: Dec 2023 ➔ Aug 2023; Portfolio reprioritization

Enrollment change • Trial completion date • Trial primary completion date • Trial termination • Inflammation

Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=88 | Suspended | Sponsor: Capella Bioscience Ltd | Recruiting ➔ Suspended

Trial suspension • Inflammation

Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers (clinicaltrials.gov) - P1 | N=88 | Recruiting | Sponsor: Capella Bioscience Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Inflammation